SEARCH BY

Issuer directory Issuer directory
KEYWORDS
COMPANIES / ISIN
TYPE OF INFORMATION
INDUSTRY

Start search  ADVANCED SEARCH

COMPARTMENTS / INDICES

France
America
Asia
Oceania
Africa
Europe

OMXC 20 NEWS

FEEDS

My RSS My Google Microsoft Live My Yahoo

COMPANY SEARCH RESULT

Genmab: Click to view the issuer\'s details

Last update : 25/05/2014  >View issuer details

2019.03.11 | 09:12 | Permanent Information Releases / Appointments

English version HTML (w) Mail

puce Genmab Announces Appointment of Marisol Peron as Head of Communications and Investor Relations - HTML (w)

2019.03.01 | 19:32 | Permanent Information Releases / Operations

English version HTML (w) Mail

puce Grant of Restricted Stock Units and Warrants to Employees in Genmab - HTML (w)

2019.02.28 | 07:58 | Annual General Meeting / AGM

English version HTML (w) Mail

puce Genmab A/S Summons Annual General Meeting - HTML (w)

2019.02.26 | 18:43 | Share History / Voting Rights and Number of Shares

English version HTML (w) Mail

puce Capital Increase in Genmab as a Result of Employee Warrant Exercise - HTML (w)

2019.02.25 | 17:47 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Genmab Announces Positive Topline Results in Phase III COLUMBA Study of Subcutaneous Daratumumab - HTML (w)

2019.02.20 | 17:18 | Permanent Information Releases / Notification of availability

English version HTML (w) Mail

puce Genmab 2018 Annual Report - HTML (w)

2019.02.12 | 07:07 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Genmab Announces U.S. FDA Approval of DARZALEX® (daratumumab) Split Dosing Regimen - HTML (w)

2019.01.31 | 17:36 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Genmab Announces that the Patent Infringement Lawsuit Relating to DARZALEX® is Over - HTML (w)

2019.01.22 | 12:44 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Genmab Announces 2018 Net Sales Figures for DARZALEX® (Daratumumab) - HTML (w)

2019.01.17 | 19:37 | Share History / Voting Rights and Number of Shares

English version HTML (w) Mail

puce Major Shareholder Announcement - HTML (w)

2019.01.08 | 18:34 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Genmab Achieves USD 75 Million Sales Milestone in DARZALEX® (daratumumab) Collaboration with Janssen - HTML (w)

Pages : 1 - 2 - 3 - 4 - 5 - 6 / Doc nb : 83